콘텐츠로 건너뛰기
Merck
모든 사진(2)

Key Documents

RAB0135

Sigma-Aldrich

Human NAP-2 / CXCL7 ELISA Kit

for serum, plasma, cell culture supernatant and urine

로그인조직 및 계약 가격 보기


About This Item

UNSPSC 코드:
41116158
NACRES:
NA.32

종 반응성

human

포장

kit of 96 wells (12 strips x 8 wells)

기술

ELISA: suitable
capture ELISA: suitable

입력

sample type urine
sample type serum
sample type cell culture supernatant(s)
sample type plasma

assay range

inter-assay cv: <12%
intra-assay cv: <10%
sensitivity: 8.5 pg/mL
standard curve range: 4.1-1000 pg/mL

검출 방법

colorimetric

배송 상태

wet ice

저장 온도

−20°C

유전자 정보

human ... PPBP(5473)

일반 설명

Platelet-derived chemokine (C-X-C motif) ligand 7 (CXCL7), also known as neutrophil-activating protein-2 (NAP-2), is a member of a subset of seven chemokines. The protein is produced in platelets and its structure contains an N-terminal glutamate-leucine-arginine (ELR) motif. It acts as a ligand for the CXC chemokine receptor 2 (CXCR2). NAP-2 facilitates the migration of bone marrow mesenchymal stem cells (MSCs) to the injury site. In addition, it also aids in monocyte recruitment during atherogenesis. The Human NAP-2 enzyme-linked immunosorbent assay (ELISA) kit is an in vitro enzyme-linked immunosorbent assay for the quantitative measurement of human NAP-2 in serum, plasma, cell culture supernatants, and urine.
The Human NAP-2 ELISA (Enzyme-Linked Immunosorbent Assay) kit is an in vitro enzyme-linked immunosorbent assay for the quantitative measurement of human NAP-2 in serum, plasma, cell culture supernatants and urine.

면역원

Recombinant Human NAP2

애플리케이션

Human NAP-2 / CXCL7 ELISA Kit has been used in enzyme-linked immunosorbent assay to quantitatively measure NAP-2/CXCL7 in serum samples of chronic myelomonocytic leukemia (CMML) patients.

기타 정보

A sample Certificate of Analysis is available for this product.
Please type the word sample in the text box provided for lot number.
For research use only. Not for use in diagnostic procedures.

키트 구성품 역시 별도로 이용 가능함

제품 번호
설명
SDS

  • RABELADAELISA 1X Assay/Sample Diluent Buffer A (Item D1)SDS

  • RABELADBELISA 5X Assay/Sample Diluent Buffer B (Item E1)SDS

  • RABSTOP3ELISA Stop Solution (Item I)SDS

  • RABTMB3ELISA Colorimetric TMB Reagent (HRP Substrate, Item H)SDS

  • RABWASH420X Wash Buffer (Item B)SDS

픽토그램

Corrosion

신호어

Warning

유해 및 위험 성명서

예방조치 성명서

Hazard Classifications

Met. Corr. 1

Storage Class Code

8A - Combustible corrosive hazardous materials


시험 성적서(COA)

제품의 로트/배치 번호를 입력하여 시험 성적서(COA)을 검색하십시오. 로트 및 배치 번호는 제품 라벨에 있는 ‘로트’ 또는 ‘배치’라는 용어 뒤에서 찾을 수 있습니다.

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문

Qian Guo et al.
Oncology reports, 37(2), 1114-1122 (2016-12-14)
CXCL7 is an important chemoattractant cytokine, which signals through binding to its receptor CXCR2. Recent studies have demonstrated that the CXCL7/CXCR2 signaling plays a promoting role in several common malignancies, including lung, renal, colon, and breast cancer. However, the regulatory
Catarina R Almeida et al.
Stem cell reports, 6(4), 466-473 (2016-04-08)
Strategies for improved homing of mesenchymal stem cells (MSCs) to a place of injury are being sought and it has been shown that natural killer (NK) cells can stimulate MSC recruitment. Here, we studied the chemokines behind this recruitment. Assays
Thomas Baltus et al.
Journal of leukocyte biology, 78(2), 435-441 (2005-05-19)
Platelet-derived chemokines, such as regulated on activation, normal T expressed and secreted (RANTES; CC chemokine ligand 5), platelet factor 4 [PF4; CXC chemokine ligand 4 (CXCL4)], and epithelial neutrophil-activating protein 78 (ENA-78; CXCL5), or precursors, such as beta-thromboglobulin, which can
Wei Jiang et al.
Experimental and therapeutic medicine, 19(4), 2449-2456 (2020-04-08)
Overuse and misuse of antibiotics leads to antibiotic resistance which has become a significant public health concern. Klebsiella pneumoniae is the most common pathogenic bacteria underlying nosocomial infections due to the expression of virulence factors and occurrence of antibiotic resistance.
Kristen Meldi et al.
The Journal of clinical investigation, 125(5), 1857-1872 (2015-03-31)
Myelodysplastic syndromes and chronic myelomonocytic leukemia (CMML) are characterized by mutations in genes encoding epigenetic modifiers and aberrant DNA methylation. DNA methyltransferase inhibitors (DMTis) are used to treat these disorders, but response is highly variable, with few means to predict

자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..

고객지원팀으로 연락바랍니다.